Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.

ClinicalTrials.gov ID: NCT00775203

Public ClinicalTrials.gov record NCT00775203. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00775203
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Labopharm Inc.
Industry
Enrollment
412 participants

Conditions and interventions

Interventions

  • Trazodone Hydrochloride (HCl) Extended-Release Tablets Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2007
Primary completion
Oct 31, 2007
Completion
Oct 31, 2007
Last update posted
Apr 26, 2012

2007

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Not listed Birmingham Alabama 35216
Not listed Mesa Arizona 85206-4616
Not listed Beverly Hills California 90210
Not listed Burbank California 91506
Not listed San Diego California 92108
Not listed Denver Colorado 80212
Not listed Gainesville Florida 32607
Not listed Hialeah Florida 33013
Not listed Jacksonville Florida 32216
Not listed Orlando Florida 32806
Not listed Tampa Florida 33613
Not listed Atlanta Georgia 30328
Not listed Marietta Georgia 30060
Not listed Smyrna Georgia 30080
Not listed Libertyville Illinois 60048
Not listed Indianapolis Indiana 46202
Not listed Overland Park Kansas 66212
Not listed Clementon New Jersey 08021
Not listed Brooklyn New York 11235
Not listed New York New York 10021
Not listed Beachwood Ohio 44122
Not listed Cincinnati Ohio 45242
Not listed Dayton Ohio 45408
Not listed Oklahoma City Oklahoma 73103
Not listed Philadelphia Pennsylvania 19149
Not listed Bellaire Texas 77401
Not listed San Antonio Texas 78229
Not listed Woodstock Vermont 05091

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00775203, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2012 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00775203 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →